Kolexia
Cassinat Bruno
Pharmacien
Hôpital Saint-Louis
Paris, France
193 Activités
25 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Myélofibrose primitive Syndromes myéloprolifératifs Polyglobulie primitive essentielle Polyglobulie Leucémies Leucémie aiguë promyélocytaire Leucémie aigüe myéloïde Thrombose Thrombocytémie essentielle

Industries

Abbvie
6 collaboration(s)
Dernière en 2023
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Exacerbation of thrombo-inflammation by JAK2V617F mutation worsens the prognosis of cerebral venous sinus thrombosis.
Blood advances   22 février 2024
Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of MIPSS70+ v2.0 over MYSEC-PM.
American journal of hematology   26 janvier 2024
Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms.
Blood cancer journal   04 janvier 2024
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification.
Leukemia   27 décembre 2023
ATG/ATLG Improves GvHD-Free and Relapse-Free Survival in Myelofibrosis Undergoing Hematopoietic Stem Cell Transplantation
65th ASH Annual Meeting Abstracts   02 novembre 2023
Impact of Arsenic Trioxide in the Treatment of Higher Risk Acute Promyelocytic Leukemia
65th ASH Annual Meeting Abstracts   02 novembre 2023
Characterization of genetic variants in the gene identified in a European collection of patients with erythrocytosis.
Haematologica   01 novembre 2023
Clinical features and genomic landscape of myeloproliferative neoplasm (MPN) patients with autoimmune and inflammatory diseases (AID).
Leukemia   11 juillet 2023
Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation.
Blood   12 juin 2023
JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023